MIRM PDUFA decision: a negative outcome, -5.7%

On April 10, 2025, Mirum Pharmaceuticals, Inc. reached its PDUFA decision. The result was a negative outcome, and the stock moved -5.7% in the window around the event. It had already run -6.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.